The Tulane National Primate Research Center was awarded a contract by the National Institutes of Health (NIH) to head a partnership linking seven federally funded National Primate Research Centers in an effort to combine strengths to accelerate promising COVID-19 vaccine and therapy research. With $1.7 million for the first year, this award goes up to $6.5 million over a four-year period. Called the Coronavirus Vaccine and Therapeutic Evaluation Network (COVTEN), Tulane serves as the coordinating site.
What’s involved with COVTEN?
Among other things, the various centers will standardize research protocols, methods and standards associated with data collection as well as a sharing of best practices as well as agreement to cooperate with the sharing of preliminary data as well as reduce actual use of nonhuman primates by introducing the concept of the “…single control group” across studies, reports Tulane University news
Principal Investigator Point of View
Jay Rappaport, principal investigator and director of the Tulane National Primate Center, shared recently, “By establishing this structure, we will maximize work being done across the NPRC’s so that we can f...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).